Clovis Oncology, Inc. (NASDAQ:CLVS) Consolidated Diluted EPS Stands At $-9.7946

0

For the period ended 2015-12-31, Clovis Oncology, Inc. (NASDAQ:CLVS) delivered annual basic consolidated EPS of $-9.7946. In terms of quarterly performance, the basic consolidated EPS was $-9.7946 for the quarter ended 2015-12-31.

What about EPS from continuing operations?

Clovis Oncology, Inc. (NASDAQ:CLVS) produced $-9.7946 in basic EPS from continuing operations for the annual period ended 2015-12-31. For the quarter, basic EPS from continuing operations was $-9.7946 for the three-month period ended 2015-12-31.

how much did parent contribute in EPS?

Clovis Oncology, Inc. (NASDAQ:CLVS) received basic EPS boost of $-9.7946 from its parent company for the annual period ended 2015-12-31. For quarterly metrics, basic EPS contribution from the parent company was $-9.7946 for the three-month period ended 2015-12-31.

Basic net EPS

Clovis Oncology, Inc. (NASDAQ:CLVS) posted basic net EPS of $-9.79 for the annual period ended 2015-12-31. On quarterly basis, the basic net EPS for the quarter ended 2015-12-31 was $-9.79.

Consolidated diluted EPS

Clovis Oncology, Inc. (NASDAQ:CLVS) produced annual consolidated diluted EPS of $-9.7946 for the period ended 2015-12-31. But consolidated diluted EPS stood at $-9.7946 for the quarter ended 2015-12-31.

Basic diluted EPS

Basic diluted EPS of $-9.7946 came from continuing operation for the annual period ended 2015-12-31. In terms of quarterly performance, diluted EPS from continuing operations was $-9.7946 for the quarter ended 2015-12-31.

Net diluted EPS

The company posted net diluted EPS of $-9.79 for the annual period ended 2015-12-31. Coming to the quarter, it posted net diluted EPS of $-9.79 for the three-month period ended 2015-12-31.

Diluted EPS from parent

Clovis Oncology, Inc. (NASDAQ:CLVS) received diluted EPS boost of $-9.7946 from the parent company for the annual period ended 2015-12-31. For the quarter, diluted EPS from the parent was $-9.7946 for the quarter ended 2015-12-31.

For the annual period ended 2015-12-31, Clovis Oncology, Inc. (NASDAQ:CLVS) produced net basic EPS of $-9.79. On quarterly basis, it posted basic net EPS of $-9.79, which was for the three-month period ended 2015-12-31.

The annual average of the company’s basic shares outstanding was 36.026 for the period ended 2015-12-31. The quarterly average of basic shares outstanding was 36.026 for the quarter ended 2015-12-31.

The company had diluted shares outstanding of 36.026 for the annual period ended 2015-12-31 and 36.026 for the quarterly period ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 2 times, 1 visits today)